Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea

INTRODUCTION: Trivalent influenza vaccines (TIVs) are currently reimbursed for subjects aged ≥ 65 years and children between 6 and 59 months of age under a national immunization program in South Korea. Quadrivalent influenza vaccines (QIVs) are expected to address the potential problem of influenza...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yun-Kyung, Song, Joon Young, Jang, Hyeongap, Kim, Tae Hyun, Koo, Heejo, Varghese, Lijoy, Han, Euna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244612/
https://www.ncbi.nlm.nih.gov/pubmed/30251078
http://dx.doi.org/10.1007/s40273-018-0715-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244612/
https://www.ncbi.nlm.nih.gov/pubmed/30251078
http://dx.doi.org/10.1007/s40273-018-0715-5

Ejemplares similares